Medical management of Cushing’s disease: what is the future?

por Fleseriu, Maria, Petersenn, Stephan
Publicado 2012

New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy

por Fleseriu, Maria, Petersenn, Stephan
Publicado 2013

Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study

por Petersenn, Stephan, Houchard, Aude, Sert, Caroline, Caron, Philippe J.
Publicado 2019

Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas

por Biller, Beverly MK, Colao, Annamaria, Petersenn, Stephan, Bonert, Vivien S, Boscaro, Marco
Publicado 2010

Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study

por Caron, Philippe J., Bevan, John S., Petersenn, Stephan, Houchard, Aude, Sert, Caroline, Webb, Susan M.
Publicado 2015

Use of Oral Concomitant Medications in Patients With Acromegaly

por Petersenn, Stephan, Houchard, Aude, Schneider, Maria del Pilar, Ribeiro-Oliveira, Antonio, Neggers, Sebastian Jcmm
Publicado 2021

Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

por Caron, Philippe J., Bevan, John S., Petersenn, Stephan, Flanagan, Daniel, Tabarin, Antoine, Prévost, Gaëtan, Maisonobe, Pascal, Clermont, Antoine
Publicado 2014

Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study

por Giustina, Andrea, Bronstein, Marcello D., Chanson, Philippe, Petersenn, Stephan, Casanueva, Felipe F., Sert, Caroline, Houchard, Aude, Melmed, Shlomo
Publicado 2019

Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?

por Petersenn, Stephan, Christ-Crain, Mirjam, Droste, Michael, Finke, Reinhard, Flitsch, Jörg, Kreitschmann-Andermahr, Ilonka, Luger, Anton, Schopohl, Jochen, Stalla, Günter
Publicado 2019

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients

por Burman, Pia, Trouillas, Jacqueline, Losa, Marco, McCormack, Ann, Petersenn, Stephan, Popovic, Vera, Theodoropoulou, Marily, Raverot, Gerald, Dekkers, Olaf M
Publicado 2022

Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study

por Findling, James W., Fleseriu, Maria, Newell-Price, John, Petersenn, Stephan, Pivonello, Rosario, Kandra, Albert, Pedroncelli, Alberto M., Biller, Beverly M. K.
Publicado 2016

Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria

por Rinke, Anja, Maintz, Christoph, Müller, Lothar, Weber, Matthias M., Lahner, Harald, Pavel, Marianne, Saeger, Wolfgang, Houchard, Aude, Ungewiss, Hanna, Petersenn, Stephan
Publicado 2021

Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac K(v)4.3 (I(to)) Channel Isoforms

por Rahm, Ann-Kathrin, Hackbarth, Juline, Müller, Mara E., Pfeiffer, Julia, Gampp, Heike, Petersenn, Finn, Rivinius, Rasmus, Frey, Norbert, Lugenbiel, Patrick, Thomas, Dierk
Publicado 2023

High variability in baseline urinary free cortisol values in patients with Cushing’s disease

por Petersenn, S, Newell-Price, J, Findling, J W, Gu, F, Maldonado, M, Sen, K, Salgado, L R, Colao, A, Biller, B M K
Publicado 2014

Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial

por Petersenn, S., Salgado, L. R., Schopohl, J., Portocarrero-Ortiz, L., Arnaldi, G., Lacroix, A., Scaroni, C., Ravichandran, S., Kandra, A., Biller, B. M. K.
Publicado 2017

Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States

por Fleseriu, Maria, Barkan, Ariel, del Pilar Schneider, Maria, Darhi, Yannis, de Pierrefeu, Amicie, Ribeiro-Oliveira, Antonio, Petersenn, Stephan, Neggers, Sebastian, Melmed, Shlomo
Publicado 2022

Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery

por Fasshauer, Mathias, Lincke, Thomas, Witzigmann, Helmut, Kluge, Regine, Tannapfel, Andrea, Moche, Michael, Buchfelder, Michael, Petersenn, Stephan, Kratzsch, Juergen, Paschke, Ralf, Koch, Christian A
Publicado 2006

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with...

por Mercado, Moises, Borges, Fatima, Bouterfa, Hakim, Chang, Tien-Chun, Chervin, Alberto, Farrall, Andrew J, Patocs, Attila, Petersenn, Stephan, Podoba, Jan, Safari, Mitra, Wardlaw, Joanna
Publicado 2007

SAGIT(®): clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study

por Giustina, Andrea, Bevan, John S., Bronstein, Marcello D., Casanueva, Felipe F., Chanson, Philippe, Petersenn, Stephan, Thanh, Xuan-Mai Truong, Sert, Caroline, Houchard, Aude, Guillemin, Isabelle, Melmed, Shlomo
Publicado 2015

Extended treatment of Cushing’s disease with pasireotide: results from a 2-year, Phase II study

por Boscaro, M., Bertherat, J., Findling, J., Fleseriu, M., Atkinson, A. B., Petersenn, S., Schopohl, J., Snyder, P., Hughes, G., Trovato, A., Hu, K., Maldonado, M., Biller, B. M. K.
Publicado 2013